About BioMedomics
BioMedomics is a company based in Durham (United States) founded in 2006.. BioMedomics has raised $1.5 million across 6 funding rounds from investors including NIH and HHS. BioMedomics offers products and services including Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests. BioMedomics operates in a competitive market with competitors including Entopsis, Tethis, GNA Biosolutions, NanoVation-GS and Hemex Health, among others.
- Headquarter Durham, United States
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biomedomics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.5 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
NIH
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioMedomics
BioMedomics offers a comprehensive portfolio of products and services, including Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid point-of-care test for sickle cell disease detection
Simplified test for large-scale sickle cell diagnostics
Tests for identifying pathogens and microorganisms
Unlock access to complete
Unlock access to complete
Funding Insights of BioMedomics
BioMedomics has successfully raised a total of $1.5M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(06 Jan 2014)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2017 | Amount | Seed - BioMedomics | Valuation |
investors |
|
| Jul, 2017 | Amount | Debt – Conventional - BioMedomics | Valuation |
investors |
|
| Sep, 2015 | Amount | Grant - BioMedomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioMedomics
BioMedomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioMedomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioMedomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomedomics Comparisons
Competitors of BioMedomics
BioMedomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Entopsis, Tethis, GNA Biosolutions, NanoVation-GS and Hemex Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic devices for health monitoring are developed using specialized slides.
|
|
| domain | founded_year | HQ Location |
Automated solutions for liquid biopsy processing are provided.
|
|
| domain | founded_year | HQ Location |
Instruments and assays for molecular pathogen detection are developed.
|
|
| domain | founded_year | HQ Location |
Nanomaterial-based sensors for respiratory monitoring devices are developed.
|
|
| domain | founded_year | HQ Location |
Platform providing care devices for the detection of tropical diseases
|
|
| domain | founded_year | HQ Location |
Nanotube-based biosensor chips are produced for real-time medical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BioMedomics
When was BioMedomics founded?
BioMedomics was founded in 2006 and raised its 1st funding round 8 years after it was founded.
Where is BioMedomics located?
BioMedomics is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Is BioMedomics a funded company?
BioMedomics is a funded company, having raised a total of $1.5M across 6 funding rounds to date. The company's 1st funding round was a Grant of $222.95K, raised on Jan 06, 2014.
What does BioMedomics do?
BioMedomics was founded in 2006 in Durham, United States, within the biotechnology sector. Point-of-care diagnostic systems for blood-based disorders are created using proprietary time-resolved lateral flow immunoassay technology and a nanotube-based platform. Operations focus on assays that have received CE marking for sickle cell anemia, hemoglobin measurement, and alpha-thalassemia detection.
Who are the top competitors of BioMedomics?
BioMedomics's top competitors include Hemex Health, Tethis and GNA Biosolutions.
What products or services does BioMedomics offer?
BioMedomics offers Sickle SCAN, Sickle SCAN EZ, and Infectious Disease Tests.